HLA-G may predict the disease course in patients with early rheumatoid arthritis

Human Immunology

Volumn 74, Issue 4, 2013, Pages 425-432

  Rizzo, Roberta ^a   Farina, Ilaria ^a   Bortolotti, Daria ^a   Galuppi, Elisa ^a   Rotola, Antonella ^a   Melchiorri, Loredana ^a   Ciancio, Giovanni ^a   Di Luca, Dario ^a   Govoni, Marcello ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; HLA G ANTIGEN; IMMUNOGLOBULIN LIKE TRANSCRIPT 2; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; EARLY RHEUMATOID ARTHRITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENETIC POLYMORPHISM; HUMAN; INDEL MUTATION; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; RHEUMATOID ARTHRITIS;

AGED; ALLELES; ANTIGENS, CD; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CYTOKINES; DNA MUTATIONAL ANALYSIS; EARLY DIAGNOSIS; EXONS; FEMALE; GENE EXPRESSION; HLA-G ANTIGENS; HUMANS; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; PROTEIN ISOFORMS; RECEPTORS, IMMUNOLOGIC;

EID: 84875079590     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.11.024     Document Type: Article

References (39)

1. Klareskog L., Catrina A.I., Paget S. Rheumatoid arthritis. Lancet 2009, 373:659-672.
2. Van der Heijde D.M. Joint erosion and patient with early reumatoid arthritis. Br J Rheumatol 1995, 34:74-78.
3. Nell V.P., Machold K.P., Eberl G., Stamm T.A., Uffmann M., Smolen J.S. Benefit of very early referral and very early therapy with diseasemodifying antirheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 2004, 43:906-914.
4. Combe B., Benessiano J., Berenbaum F., Cantagrel A., Daurès J.P., Dougados M., et al. The ESPOIR cohort: a ten year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint Bone Spine 2007, 74:440-445.
5. Quinn M.A., Cox S. The evidence for early intervention. Rheum Dis North Am 2005, 31:575-589.
6. Amjadi-Begvand S., Khanna D., Park G.S., Bulpitt K.J., Wong W.K., Paulus H.E. Dating the window of therapeutic opportunity in early rheumatoid arthritis: accuracy of patient recall of arthritis symptom onset. J Rheumatol 2004, 31:1686-1692.
7. Naredo E., Bonilla G., Gamero F., Uson J., Carmona L., Laffon A. Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis 2005, 64:375-381.
8. Kawashiri S.Y., Kawakami A., Iwamoto N., Fujikawa K., Satoh K., Tamai M., et al. The power Doppler ultrasonography score from 24 synovial sites or 6 simplified synovial sites, including the metacarpophalangeal joints, reflects the clinical disease activity and level of serum biomarkers in patients with rheumatoid arthritis. Rheumatology 2011, 50:962-965.
9. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990, 248:220-223.
10. Carosella E.D. The tolerogenic molecule HLA-G. Immunol Lett 2011, 138:22-24.
11. Ishitani A., Geraghty D. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both Class I and Class II antigens. Proc Natl Acad Sci USA 1992, 89:3947-3951.
12. + cells by interacting with CD8. J Immunol 2000, 164:6100-6104.
13. Du L., Xiao X., Wang C., Zhang X., Zheng N., Wang L., et al. Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells. Cancer Sci 2011, 102:1272-1280.
14. Marchal-Bras-Goncalves R., Rouas-Freiss N., Connan F., Choppin J., Dausset J., Carosella E.D., et al. A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc 2001, 33:2355-2359.
15. Liang S., Ristich V., Arase H., Dausset J., Carosella E.D., Horuzsko A. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway. Proc Natl Acad Sci USA 2008, 105:8357-8362.
16. Kapasi K., Albert S.E., Yie S., Zavazava N., Librach C.L. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 2000, 101:191-200.
17. LeMaoult J., Zafaranloo K., Le Danff C., Carosella E.D. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 2005, 19:662-664.
18. Hviid T.V., Rizzo R., Christiansen O.B., Melchiorri L., Lindhard A., Baricordi O.R. HLA-G and IL-10 in plasma in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004, 56:135-141.
19. Verbruggen L.A., Rebmann V., Demanet C., De Cock S., Grosse-Wilde H. Soluble HLA-G in rheumatoid arthritis. Hum Immunol 2006, 67:561-567.
20. Prigione I., Penco, Martini A., Gattorno M., Pistoia V., Morandi F. HLA-G and HLA-E in patients with juvenile idiopathic arthritis. Rheumatology 2011, 50:966-972.
21. Ongaro A., Stignani M., Pellati A., Melchiorri L., Massari L., Caruso G., et al. Human leukocyte antigen-G molecules are constitutively expressed by synovial fibroblasts and upmodulated in osteoarthritis. Hum Immunol 2010, 71:342-350.
22. Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010, 62:2569-2581.
23. Backhaus M., Burmester G.R., Gerber T., Grassi W., Machold K.P., Swen W.A. Working group for musculoskeletal ultrasound in the EULAR standing committee on International Clinical Studies including Therapeutic Trials. Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis 2001, 60:641-649.
24. Szkudlarek M., Court-Payen M., Jacobsen S., Klarlund M., Thomsen H.S., Østergaard M. Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum 2003, 48:955-962.
25. Andrew Filer, Paola de Pablo, Gina Allen, Peter Nightingale, Alison Jordan, Paresh Jobanputra, et al. Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis. Ann Rheum Dis 2011, 70:500-507.
26. Djurisic S., Sørensen A.E., Hviid T.V. A fast and easy real-time PCR genotyping method for the HLA-G 14-bp insertion/deletion polymorphism in the 3' untranslated region. Tissue Antigens 2012, 79:186-189.
27. Fainardi E., Rizzo R., Melchiorri L., Stignani M., Castellazzi M., Tamborino C., et al. CSF levels of soluble HLA-G and fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis. Mult Scler 2008, 14:446-454.
28. Wright H.L., Bucknall R.C., Moots R.J., Edwards S.W. Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy. Rheumatology 2012, 51:451-459.
29. Rebmann V., Busemann A., Lindemann M., Grosse-Wilde H. Detection of HLA-G5 secreting cells. Hum Immunol 2003, 64:1017-1024.
30. Combe B., Landewe R., Lukas C., Bolosiu H.D., Breedveld F., Dougados M., et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007, 66:34-45.
31. de Wit M.P., Smolen J.S., Gossec L., van der Heijde D.M. Treating rheumatoid arthritis to target: the patient version of the international recommendations. Ann Rheum Dis 2011, 70:891-895.
32. Rizzo R., Rubini M., Govoni M., Padovan M., Melchiorri L., Stignani M., et al. HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharmacogenet Genomics 2006, 16:615-623.
33. van der Graaff W.L., Prins A.P., Dijkmans B.A., van Lier R.A. Prognostic value of Th1/Th2 ratio in rheumatoid arthritis. Lancet 1998, 351:1931.
34. Marti L., Golmia R., Golmia A.P., Paes A.T., Guilhen D.D., Moreira-Filho C.A., et al. Alterations in cytokine profile and dendritic cells subsets in peripheral blood of rheumatoid arthritis patients before and after biologic therapy. Ann NY Acad Sci 2009, 1173:334-342.
35. Schulze-Koops H., Lipsky P.E., Kavanaugh A.F., Davis L.S. Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefit. J Immunol 1995, 155:5029-5037.
36. Skapenko A., Wendler J., Lipsky P.E., Kalden J.R., Schulze-Koops H. Altered memory T cell differentiation in patients with early rheumatoid arthritis. J Immunol 1999, 163:491-499.
37. Rizzo R., Hviid T.V., Stignani M., Balboni A., Grappa M.T., Melchiorri L. Baricordi OR The HLA-G genotype is associated with IL-10 levels in activated PBMCs. Immunogenetics 2005, 57:172-181.
38. Stamp L.K., O'Donnell J.L., Chapman P.T., Barclay M.L., Kennedy M.A., Frampton C.M., et al. Lack of association between HLA-G 14 bp insertion/deletion polymorphism and response to long-term therapy with methotrexate response in rheumatoid arthritis. Ann Rheum Dis 2009, 68:154-155.
39. Kooloos W.M., Wessels J.A., van der Straaten T., Allaart C.F., Huizinga T.W., Guchelaar H.J. Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis. Pharmacogenomics 2010, 11:163-175.